Human Vaccines & Immunotherapeutics: News

Mostrar otras versiones (9)

DNA vaccine for T1D promising in the clinic HPV vaccines halved infections in US teenage girls Modified DC immunotherapy against melanoma New study looks at clinical severity of human H7N9 infections Prevnar vaccines are valuable for healthcare systems GAPVAC: New consortium in the fight of brain ca...

Descripción completa

Detalles Bibliográficos
Autor principal: Riedmann, Eva M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
News, Policy & Profiles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906255/
http://dx.doi.org/10.4161/hv.26189
_version_ 1782301466806976512
author Riedmann, Eva M
author_facet Riedmann, Eva M
author_sort Riedmann, Eva M
collection PubMed
description DNA vaccine for T1D promising in the clinic HPV vaccines halved infections in US teenage girls Modified DC immunotherapy against melanoma New study looks at clinical severity of human H7N9 infections Prevnar vaccines are valuable for healthcare systems GAPVAC: New consortium in the fight of brain cancer Cytomegalovirus vaccine to enter phase 3 Malaria vaccination using chemically attenuated parasites
format Online
Article
Text
id pubmed-3906255
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-39062552014-02-04 Human Vaccines & Immunotherapeutics: News Riedmann, Eva M Hum Vaccin Immunother News, Policy & Profiles DNA vaccine for T1D promising in the clinic HPV vaccines halved infections in US teenage girls Modified DC immunotherapy against melanoma New study looks at clinical severity of human H7N9 infections Prevnar vaccines are valuable for healthcare systems GAPVAC: New consortium in the fight of brain cancer Cytomegalovirus vaccine to enter phase 3 Malaria vaccination using chemically attenuated parasites Landes Bioscience 2013-08-01 2013-08-16 /pmc/articles/PMC3906255/ http://dx.doi.org/10.4161/hv.26189 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle News, Policy & Profiles
Riedmann, Eva M
Human Vaccines & Immunotherapeutics: News
title Human Vaccines & Immunotherapeutics: News
title_full Human Vaccines & Immunotherapeutics: News
title_fullStr Human Vaccines & Immunotherapeutics: News
title_full_unstemmed Human Vaccines & Immunotherapeutics: News
title_short Human Vaccines & Immunotherapeutics: News
title_sort human vaccines & immunotherapeutics: news
topic News, Policy & Profiles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906255/
http://dx.doi.org/10.4161/hv.26189
work_keys_str_mv AT riedmannevam humanvaccinesimmunotherapeuticsnews

Ejemplares similares